Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
11:00am, Thursday, 21'st May 2026
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care PR Newswire
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
10:13am, Thursday, 21'st May 2026
Shareholders approve proposed dividend of EUR 1.49 per share FME Reignite strategy launched in 2025 successfully drives the next phase of value creation 5008X CAREsystem introduced in U.S. clinics; fu
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
02:00pm, Wednesday, 20'th May 2026
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer PR Newswire BAD HOMBURG, Germany, May 2
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
01:00pm, Wednesday, 20'th May 2026
BAD HOMBURG, Germany, May 20, 2026 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease, today
FMS Stock Rises Despite Q1 Earnings & Sales Miss, Margins Expand
12:41pm, Wednesday, 06'th May 2026
Fresenius Medical's shares rise after Q1 earnings miss estimates as margin expansion and FME25+ savings support operating income growth.
Fresenius Medical Care AG (FMS) Q1 2026 Earnings Call Transcript
04:01pm, Tuesday, 05'th May 2026
Fresenius Medical Care AG (FMS) Q1 2026 Earnings Call Transcript
Fresenius Medical: The Undervaluation Is Getting Clearer
12:09pm, Tuesday, 05'th May 2026
Fresenius Medical Care is undervalued at a sub-10x P/E despite 7-9% AEPS growth and improved fundamentals. FMS has achieved 300-400 bps margin expansion, €800M+ in savings, and reduced leverage to 2
Organic revenue growth1 of 4% with growth in all operating segments Operating income2 grew 10%, resulting in further margin expansion to 10.1% FME25+ transformation program related one-time costs ma
Fresenius Medical Care Posts Lower Net Profit on One-Off Costs
03:22am, Tuesday, 05'th May 2026
The dialysis specialist started restructuring its U.S. network by exiting 64 of up to 100 clinics.
Fresenius Medical Care's revenue falls in Q1 as weak dollar takes toll
01:08am, Tuesday, 05'th May 2026
Fresenius Medical Care said on Tuesday its revenue fell 6% in the first quarter of 2026, weighed down by significant currency effects, mainly from the weak U.S. dollar, and recent
On April 15, 2026, JB Hunt Transport Services Inc (JBHT) released its 8-K filing reporting first-quarter 2026 results. The company posted U.S. GAAP revenue of $
Reviewing Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Bluejay Diagnostics (NASDAQ:BJDX)
01:44am, Monday, 13'th Apr 2026
Fresenius Medical Care AG and Co. KGaA (NYSE: FMS - Get Free Report) and Bluejay Diagnostics (NASDAQ: BJDX - Get Free Report) are both medical companies, but which is the better business? We will comp
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
10:40am, Thursday, 09'th Apr 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
12:16pm, Wednesday, 25'th Mar 2026
FMS eyes growth on value-based care surge and FME25+ savings, but regulatory headwinds, flat volumes and China weakness cloud outlook.
Fresenius (FMS) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Tuesday, 24'th Mar 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
